Detalhe da pesquisa
1.
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.
J Oral Maxillofac Surg
; 72(10): 1938-56, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25234529
2.
Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management.
Annu Rev Med
; 60: 85-96, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-18928335
3.
Safety profile of intravenous bisphosphonates.
Semin Oncol
; 34(6 Suppl 4): S24-7, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18068487
4.
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.
J Oral Maxillofac Surg
; 67(5 Suppl): 2-12, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19371809
5.
Ten years of alendronate treatment for osteoporosis in postmenopausal women.
N Engl J Med
; 351(2): 190-2; author reply 190-2, 2004 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-15250063
6.
Bisphosphonate complications including osteonecrosis of the jaw.
Hematology Am Soc Hematol Educ Program
; : 356-60, 515, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17124083
7.
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.
J Oral Maxillofac Surg
; 62(5): 527-34, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15122554
8.
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.
Aust Endod J
; 35(3): 119-30, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19961450